Приказ основних података о документу

dc.creatorVukašinović, Aleksandra
dc.creatorOstanek, Barbara
dc.creatorKlisić, Aleksandra
dc.creatorKafedžić, Srđan
dc.creatorZdravković, Marija
dc.creatorIlić, Ivan
dc.creatorSopić, Miron
dc.creatorHinić, Saša
dc.creatorStefanović, Milica
dc.creatorMemon, Lidija
dc.creatorGaković, Branka
dc.creatorBogavac-Stanojević, Nataša
dc.creatorSpasojević-Kalimanovska, Vesna
dc.creatorMarc, Janja
dc.creatorNešković, Aleksandar
dc.creatorKotur-Stevuljević, Jelena
dc.date.accessioned2023-04-25T16:51:11Z
dc.date.available2023-04-25T16:51:11Z
dc.date.issued2023
dc.identifier.issn1734-1922
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/4677
dc.description.abstractIntroduction: Telomeres are protective chromosomal ends. Short telomeres are a proven biomarker of biological aging. We aimed to find an association of telomere length and telomerase activity in circulating leukocytes and thromboaspirates of patients with acute myocardial infarction. Furthermore, association of the telomere-telomerase system with oxidative stress markers (as common risk factors for coronary artery disease (CAD)) was tested. Material and methods: Patients were selected from the patients admitted to the intensive care unit with acute myocardial infarction with ST-segment elevation (STEMI), with the following inclusion criteria – STEMI patients between 18 and 80 years old of both genders and candidates for primary percutaneous coronary intervention, with infarction pain present for a maximum of 12 h. In all the patients leukocyte telomere length, telomerase activity and scores related to oxidative-stress status (Protective, Damage and OXY) were evaluated. Results: Patients were divided into different groups: with stable angina pectoris (AP) (n = 22), acute myocardial infarction with: STEMI (n = 93), non-obstructive coronary arteries (MINOCA) (n = 7), blood vessel rupture (n = 6) at three time points, and compared to the group of 84 healthy subjects. Telomerase activity was significantly higher in all CAD sub-groups compared to the control group (AP = 0.373 (0.355–0.386), STEMI = 0.375 (0.349–0.395), MINOCA = 0.391 (0.366–0.401), blood vessel rupture = 0.360 (0.352–0.385) vs. CG = 0.069 (0.061–0.081), p < 0.001), while telomeres were significantly shorter in STEMI, MINOCA and blood vessel rupture groups compared to the control group (STEMI = 1.179 (0.931–1.376), MINOCA = 1.026 (0.951–1.070), blood vessel rupture = 1.089 (0.842–1.173) vs. CG = 1.329 (1.096–1.624), p = 0.030]. Values of OXY score were significantly higher in STEMI and MINOCA patients compared to the control group and AP patients (5.83 (4.55–7.54) and 10.28 (9.19–10.72) vs. 4.94 (3.29–6.18) and 4.18 (2.58–4.86), p < 0.001). Longer telomeres and higher telomerase activity were found in thromboaspirates, compared to the peripheral blood leukocytes in the same patients (1.25 (1.01–1.84) vs. 1.18 (0.909–1.516), p = 0.036; and 0.366 (0.367–0.379) vs. 0.366 (0.367–0.379), p < 0.001, respectively). In addition, telomere length and telomerase activity had good diagnostic ability to separate STEMI patients from healthy persons. Conclusions: Leukocyte telomere length and telomerase activity can differentiate CAD patients from healthy persons, and relate CAD to oxidative stress.
dc.publisherTermedia Publishing House Ltd.
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//
dc.relationSlovenian Research Agency (Grants P3-0298 and J3-5511)
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.sourceArchives of Medical Science
dc.subjectoxidative stress
dc.subjectcardiovascular disease
dc.subjecttelomerase activity
dc.subjecttelomere length
dc.titleTelomere-telomerase system status in patients with acute myocardial infarction with ST-segment elevation – relationship with oxidative stress
dc.typearticle
dc.rights.licenseBY-NC-SA
dc.citation.volume19
dc.citation.issue2
dc.citation.spage313
dc.citation.epage323
dc.citation.rankM22~
dc.identifier.wos000980693500006
dc.identifier.doi10.5114/aoms/136074
dc.identifier.pmid37034531
dc.identifier.scopus2-s2.0-85152284909
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs/bitstream/id/12673/Telomere-telomerase_system_status_pub_2023.pdf
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу